VRPX insider filings
Virpax Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-07-10. Screen VRPX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for VRPX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Virpax Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-10 | 4 | Field Katharyn — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-07-09 | 4 | Dhaliwal Jatinder — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-07-09 | 4 | Herman Gary L — Director | Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Singh Vanila — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Shah Vinay — Chief Financial Officer | Grant/award (A): 112,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Jambulingam Thani — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Mathias Sheila — Chief Scientific Officer | Grant/award (A): 112,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Dubin Michael F — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Sendrow Jerrold — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Floyd Eric — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Ruskin Barbara — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Bruce Gerald W — Chief Executive Officer, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-08-16 | 4/A | Shah Vinay — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Shah Vinay — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-04-26 | 4 | Bruce Gerald W — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-03-28 | 4 | Ruskin Barbara — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-02-07 | 4/A | Mack Anthony P. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-01-27 | 4 | Gudin Jeffrey — Chief Medical Officer, Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2023-01-27 | 4 | Mack Anthony P. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-01-27 | 4 | Chipman Christopher Michael — Chief Financial Officer | Grant/award (A): 112,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Jambulingam Thani — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Floyd Eric — Director | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Sendrow Jerrold — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Dubin Michael F — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Singh Vanila — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Sendrow Jerrold — Director | Purchase (P): 4,500 @ $1.29 | EDGAR |
| 2022-05-20 | 4 | Mack Anthony P. — Chief Executive Officer, Director | Purchase (P): 75,750 @ $1.34 | EDGAR |
| 2022-05-20 | 4 | Floyd Eric — Director | Purchase (P): 4,479 @ $1.36 | EDGAR |
| 2022-04-27 | 4 | Bruce Gerald W — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4/A | Mack Anthony P. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 60,676 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4/A | Gudin Jeffrey — Chief Medical Officer, Director | Grant/award (A): 60,676 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4/A | Chipman Christopher Michael — Chief Financial Officer | Grant/award (A): 60,676 (derivative) @ $0 | EDGAR |
| 2022-02-02 | 4 | Mack Anthony P. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-02-02 | 4 | Gudin Jeffrey — Chief Medical Officer, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-02-02 | 4 | Chipman Christopher Michael — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Sendrow Jerrold — Director | Grant/award (A): 12,091 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Jambulingam Thani — Director | Grant/award (A): 14,113 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Singh Vanila — Director | Grant/award (A): 12,091 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Dubin Michael F — Director | Grant/award (A): 12,091 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Floyd Eric — Director | Grant/award (A): 15,124 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | JACOB GARY S — Director | Grant/award (A): 12,091 (derivative) @ $0 | EDGAR |
| 2021-11-24 | 4 | Sendrow Jerrold — Director | Purchase (P): 3,900 @ $3.92 | EDGAR |
| 2021-11-22 | 4 | Mack Anthony P. — Chief Executive Officer, Director, 10% owner | Purchase (P): 25,125 @ $3.99 | EDGAR |
| 2021-08-05 | 4 | Dubin Michael F — Director | Grant/award (A): 20,225 (derivative) @ $0 | EDGAR |
| 2021-04-09 | 4 | Sendrow Jerrold — Director | Grant/award (A): 10,205 (derivative) @ $0 | EDGAR |
| 2021-04-09 | 4 | Floyd Eric — Director | Grant/award (A): 11,216 (derivative) @ $0 | EDGAR |
| 2021-04-09 | 4 | Mack Anthony P. — Chief Executive Officer, Director, 10% owner | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-04-09 | 4 | Bruce Gerald W — EVP, Commercial Operations | Holdings only — no transactions reported | EDGAR |
| 2021-04-09 | 4 | Chipman Christopher Michael — Chief Financial Officer | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-04-09 | 4 | JACOB GARY S — Director | Grant/award (A): 13,183 (derivative) @ $0 | EDGAR |
Recent 8-K events — Virpax Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-04-03 | 8-K/A | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-03 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-21 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-15 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-01-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VRPX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs